|
Differntial gene expression between RNA A-to-I edited versus non-edited samples | |
The effects of the RNA editing to the stability of the RNA structures | |
Gene summary for IFI30 |
Gene summary |
Gene information | Gene symbol | IFI30 | Gene ID | 10437 |
Gene name | IFI30 lysosomal thiol reductase | |
Synonyms | GILT|IFI-30|IP-30|IP30 | |
Cytomap | 19p13.11 | |
Type of gene | protein-coding | |
Description | gamma-interferon-inducible lysosomal thiol reductasegamma-interferon-inducible protein IP-30interferon gamma-inducible protein 30 preproproteininterferon, gamma-inducible protein 30legumaturain | |
Modification date | 20200313 | |
UniProtAcc | P13284, | |
Context |
Gene ontology of each this gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Gene | GO ID | GO term | PubMed ID |
Top |
RNA A-to-I events for IFI30 |
RNA A-to-I editing events in the ROSMAP, MSBB, and Mayo data sets based on Ensembl gene isoform structure. * This pie chart shows the number of RNA A-to-I editing events in different types of transcripts (# event, percentage). |
RNA editing frequencies across three data sets. |
The number of RNA A-to-I editing events in different types of transcripts (# event, percentage). |
RNA A-to-I editing events in AD. |
ADediting_722718(18173937, +), ADediting_722719(18177741, +), |
Top |
RNA editing positional annotations for IFI30 using Annovar |
Protein coding RNA editing(s). |
ADeditome ID | Position | Variant type | ENST | NTchange | AAchange | SIFT_score | Polyphen2_HVAR_score | PROVEAN_pred |
ADediting_722718 | chr19_18173937_+ | synonymous SNV | ENST00000407280.4 | c.A96G | p.L32L | . | . | . |
ADediting_722718 | chr19_18173937_+ | synonymous SNV | ENST00000597802.2 | c.A96G | p.L32L | . | . | . |
ADediting_722719 | chr19_18177741_+ | nonsynonymous SNV | ENST00000407280.4 | c.A667G | p.T223A | 0.532 | 0.0 | -1.51 |
Gene structure information of RNA editing(s). |
ADeditome ID | Position | Variant type |
ADediting_722718 | chr19_18173937_+ | exonic |
ADediting_722719 | chr19_18177741_+ | exonic |
Repat-regional RNA editing(s). |
ADeditome ID | Position | Repeat family | Repeat sub family | Repeat name |
Top |
RNA A-to-I editing events in the alternative splicing sites for IFI30 |
RNA A-to-I editing(s) in the alternative splicing sites. |
AStype | ADeditomID | Editing position | AS position | AS direction | Exonic location | Wildtype sequence | Wildtype splicing strength | RNA edited sequence | RNA edited splicing strength |
Differential pencent of spliced in (PSI) between RNA A-to-I edited and non-edited samples |
Top |
Differntial gene expression between RNA A-to-I edited versus non-edited samples for IFI30 |
Distribution of the averaged gene expression in AD and control with or without RNA A-to-I editing event. * The grey color means N/A. |
Distribution of the averaged gene isoform expression in AD and control with or without RNA A-to-I editing event. |
- Differentially expressed gene between RNA A-to-I edited samples versus non-edited samples. * Click on the image to enlarge it in a new window. |
- Differentially expressed transcript between RNA A-to-I edited samples versus non-edited samples. * Click on the image to enlarge it in a new window. |
ADeditome ID | Chr | Positoing | Skipped exon | ENSG | ENSTs |
Top |
Protein coding region RNA A-to-I editings for IFI30 |
- Lollipop plot for RNA A-to-I editings across protein structure. * Click on the image to enlarge it in a new window. |
Top |
The effects of the RNA editing to the miRNA binding sites for IFI30 |
RNA A-to-I editing in the 3'-UTR regions of mRNA gained miRNA binding sites. |
ADeditom_ID | Position | ENSG | ENST | Transcript name | miRNA ID | Chromosome | Targt | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
RNA A-to-I editing in the 3'-UTR regions of mRNA lost miRNA binding sites. |
ADeditom_ID | Position | ENSG | ENST | Transcript name | miRNA ID | Chromosome | Targt | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
RNA A-to-I editing in lncRNA gained miRNA binding sites. |
ADeditom_ID | Position | ENSG | ENST | Transcript name | miRNA ID | Chromosome | Targt | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
RNA A-to-I editing in lncRNA lost miRNA binding sites. |
ADeditom_ID | Position | ENSG | ENST | Transcript name | miRNA ID | Chromosome | Targt | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
RNA A-to-I editing in miRNAs gained binding to lncRNA. |
ADeditom_ID | Position | ENSG | ENST | Transcript name | miRNA ID | Chromosome | Targt | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
RNA A-to-I editing in miRNAs lost binding to lncRNA. |
ADeditom_ID | Position | ENSG | ENST | Transcript name | miRNA ID | Chromosome | Targt | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
RNA A-to-I editing in miRNAs gained binding to the 3'-UTR region of mRNA. |
ADeditom_ID | Position | ENSG | ENST | Transcript name | miRNA ID | Chromosome | Targt | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
RNA A-to-I editing in miRNAs lost binding to the 3'-UTR mRNA. |
ADeditom_ID | Position | ENSG | ENST | Transcript name | miRNA ID | Chromosome | Targt | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
ADediting_1643790 | chr3_121049689_+ | ENSG00000216490.4 | ENST00000407280.4 | IFI30-201 | hsa-miR-5682 | chr19 | 18178088 | 18178095 | 8mer-1a | 18178074 | 18178095 | 144 | -12.11 |
Differentially expressed gene-miRNA network |
Top |
The effects of the RNA editing to the stability of the RNA structures for IFI30 |
- RNA A-to-I editing in mRNA. * Click on the image to enlarge it in a new window. |
ENST | ENST type | RNA structure without RNA A-to-I editing. | RNA structure with RNA A-to-I editing. |
ENST00000597802.2 | protein_coding | ||
ENST00000407280.4 | protein_coding |
RNA A-to-I editing in miRNA. |
ADeditom_ID | ENST | mir_ID | Editing_Information | Editing_Position | MFE_withoneAI | MFE_withoutAI | MFE_withmultipleAI |
RNA A-to-I editing in mRNA. |
ADeditom_ID | ENST | Editing_Information | Editing_Position | MFE_withoneAI | MFE_withoutAI | MFE_withmultipleAI |
ADediting_722718 | ENST00000597802.2 | chr19_18173937_+ | 192 | -156.40 | -149.80 | -156.40 |
ADediting_722718 | ENST00000407280.4 | chr19_18173937_+ | 125 | -344.60 | -338.00 | -351.30 |
ADediting_722719 | ENST00000407280.4 | chr19_18177741_+ | 696 | -344.70 | -338.00 | -351.30 |
RNA A-to-I editing in lncRNA. |
ADeditom_ID | ENST | Editing_Information | Editing_Position | MFE_withoneAI | MFE_withoutAI | MFE_withmultipleAI |
Top |
Relation with ADAR for IFI30 |
Correlation between ADAR gene expression and RNA editing frequency |
Tissue | ADeditomID | position | ADAR1 (p-val) | ADAR1 (coeff.) | ADAR2 (p-val) | ADAR2 (coeff.) | ADAR3 (p-val) | ADAR3 (coeff.) |
Correlation between ADAR gene expression and this gene's expression |
Tissue | ADAR1 (p-val) | ADAR1 (coeff.) | ADAR2 (p-val) | ADAR2 (coeff.) | ADAR3 (p-val) | ADAR3 (coeff.) |
AC | 6.86999731536403e-36 | 0.684416197467195 | 2.61478989638991e-18 | 0.514652362559119 | 2.92231187290206e-05 | 0.261041535893502 |
Top |
Relation with AD stages for IFI30 |
Correlation between AD stages and RNA editing frequency |
Tissue | ADeditomID | position | P-val | Coeff. |
Correlation between AD stages and this gene's expression |
Tissue | P-val | Coeff. |
TCX | 0.000205828456740076 | 0.353023418853885 |
Top |
RelatedDrugs for IFI30 |
Approved drugs targeting this gene. (DrugBank Version 5.1.0 2018-04-02) |
Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for IFI30 |
Diseases associated with this gene. (DisGeNet 4.0) |
Gene | Disease ID | Disease name | # pubmeds | Source |
IFI30 | C0023467 | Leukemia, Myelocytic, Acute | 1 | CTD_human |
IFI30 | C0026998 | Acute Myeloid Leukemia, M1 | 1 | CTD_human |
IFI30 | C0162820 | Dermatitis, Allergic Contact | 1 | CTD_human |
IFI30 | C1879321 | Acute Myeloid Leukemia (AML-M2) | 1 | CTD_human |